Cargando…

Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer’s disease 

Alzheimer’s disease (AD)—a complex disease showing multiple pathomechanistic alterations—is triggered by nonlinear dynamic interactions of genetic/epigenetic and environmental risk factors, which, ultimately, converge into a biologically heterogeneous disease. To tackle the burden of AD during early...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hampel, Harald, Vergallo, Andrea, Afshar, Mohammad, Akman-Anderson, Leyla, Arenas, Joaquín, Benda, Norbert, Batrla, Richard, Broich, Karl, Caraci, Filippo, Cuello, A. Claudio, Emanuele, Enzo, Haberkamp, Marion, Kiddle, Steven J., Lucía, Alejandro, Mapstone, Mark, Verdooner, Steven R., Woodcock, Janet, Lista, Simone
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Les Laboratoires Servier 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787542/ https://www.ncbi.nlm.nih.gov/pubmed/31636492 http://dx.doi.org/10.31887/DCNS.2019.21.2/hhampel

Ejemplares similares

A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease
por: Hampel, Harald, et al.
Publicado: (2020)

β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification
por: Hampel, Harald, et al.
Publicado: (2020)

Biological Mechanism-based Neurology and Psychiatry: A BACE1/2 and Downstream Pathway Model
por: Hampel, Harald, et al.
Publicado: (2023)

Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology
por: Hampel, Harald, et al.
Publicado: (2019)

Biomarkers for Alzheimer’s Disease (AD) and the Application of Precision Medicine
por: Lukiw, Walter J., et al.
Publicado: (2020)

The Sars-Cov-2 Pandemic and the Brave New Digital World of Environmental Enrichment to Prevent Brain Aging and Cognitive Decline
por: Hampel, Harald, et al.
Publicado: (2020)

Biological markers for early detection and pharmacological treatment of Alzheimer's disease
por: Hampel, Harald, et al.
Publicado: (2009)

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)
por: Zhao, Yuhai, et al.
Publicado: (2020)

Aptamarker prediction of brain amyloid-β status in cognitively normal individuals at risk for Alzheimer’s disease
por: Penner, Gregory, et al.
Publicado: (2021)

Have we learnt all we need to know from genetic studies - is genetics over in Alzheimer's disease?
por: Hampel, Harald, et al.
Publicado: (2013)

Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study
por: Baldacci, Filippo, et al.
Publicado: (2020)

MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints
por: Vergallo, Andrea, et al.
Publicado: (2021)

Partial Volume Correction Increases the Sensitivity of 18F-Florbetapir-Positron Emission Tomography for the Detection of Early Stage Amyloidosis
por: Teipel, Stefan J., et al.
Publicado: (2021)

Biomarker-guided classification scheme of neurodegenerative diseases
por: Baldacci, Filippo, et al.
Publicado: (2016)

Evaluation of major national dementia policies and health‐care system preparedness for early medical action and implementation
por: Hampel, Harald, et al.
Publicado: (2022)

Differential response to donepezil in MRI subtypes of mild cognitive impairment
por: Diaz-Galvan, Patricia, et al.
Publicado: (2023)

Correction: Differential response to donepezil in MRI subtypes of mild cognitive impairment
por: Diaz‑Galvan, Patricia, et al.
Publicado: (2023)

Biomarker candidates of neurodegeneration in Parkinson’s disease for the evaluation of disease-modifying therapeutics
por: Gerlach, Manfred, et al.
Publicado: (2011)

The Clinical and Health Economic Value of Clinical Laboratory Diagnostics
por: Jordan, Bruce, et al.
Publicado: (2015)

Meet the Co-Editor
por: Caraci, Filippo
Publicado: (2022)

Meet the Co-Editor
por: Caraci, Filippo
Publicado: (2023)

Dos and don’ts in response priming research
por: Schmidt, Filipp, et al.
Publicado: (2011)

Challenges and Pitfalls of Using Repeat Spirometry Recordings in Routine Primary Care Data to Measure FEV(1) Decline in a COPD Population
por: Whittaker, Hannah R, et al.
Publicado: (2021)

Aptamers as biomarkers for neurological disorders. Proof of concept in transgenic mice
por: Lecocq, Soizic, et al.
Publicado: (2018)

Bioequivalence, Drugs with Narrow Therapeutic Index and the Phenomenon of Biocreep: A Critical Analysis of the System for Generic Substitution
por: Gozzo, Lucia, et al.
Publicado: (2022)

Evaluation and comparison of the new swept source OCT-based IOLMaster 700 with the IOLMaster 500
por: Akman, Ahmet, et al.
Publicado: (2016)

Successful aging: insights from proteome analyses of healthy centenarians
por: Santos-Lozano, Alejandro, et al.
Publicado: (2020)

MF-PCBA: Multifidelity High-Throughput Screening Benchmarks for Drug Discovery and Machine Learning
por: Buterez, David, et al.
Publicado: (2023)

Personalized health care beyond oncology: new indications for immunoassay‐based companion diagnostics
por: Batrla, Richard, et al.
Publicado: (2015)

DiGA unterstützen die moderne Versorgung
por: Broich, Karl
Publicado: (2022)

Alzheimer's disease: are blood and brain markers related? A systematic review
por: Khan, Ali T., et al.
Publicado: (2016)

Characteristics, service use and mortality of clusters of multimorbid patients in England: a population-based study
por: Zhu, Yajing, et al.
Publicado: (2020)

A Sustainable Approach to Delivering Programmable Peer-to-Peer Offline Payments
por: Mainetti, Luca, et al.
Publicado: (2023)

Pyridinic Nanographenes by Novel Precursor Design
por: Reger, David, et al.
Publicado: (2021)

A case report of coronary artery spasm and takotsubo syndrome: exploring the hidden side of the moon
por: Lombardi, Marco, et al.
Publicado: (2020)

Migraine: An Overview
por: Salomone, Salvatore, et al.
Publicado: (2009)

Metacognitive Change During Exposure and Metacognitive Therapy in Obsessive-Compulsive Disorder
por: Hansmeier, Jana, et al.
Publicado: (2021)

The Behavior Avoidance Test: Association With Symptom Severity and Treatment Outcome in Obsessive-Compulsive Disorder
por: Hansmeier, Jana, et al.
Publicado: (2021)

Reduced basal forebrain atrophy progression in a randomized Donepezil trial in prodromal Alzheimer’s disease
por: Cavedo, Enrica, et al.
Publicado: (2017)

Early Clinical Features of Pseudoexfoliation Syndrome in Anterior Segment and Gonioscopy Examination
por: Gür Güngör, Sirel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e6rf8rqndq81olq7li55nrcc6c